Why the study?
Do statins alter the progression of calcific aortic valve stenosis?
Do statins alter the progression of calcific aortic valve stenosis?
Despite pathophysiological similarities to atherosclerosis and promising retrospective data, randomized trials have not supported the use of statins to prevent the progression of calcific aortic stenosis.
Answers are grounded in this paper and cite their sources.
No support for statins to slow aortic stenosis progression; confirms RCT results over retrospective signals and leaves open alternative targets.
Calcific aortic valve stenosis is the most frequent valve disease and the most common cause of aortic valve replacement in the western world, concomitant with aging of the general population and habitual consumption of a high-calorie diet. For years it was considered to be a passive wear and tear process but now it is recognized as an active process similar to atherosclerosis with involvement of several mediators, such as adhesion molecules, TGFs, cathepsin enzymes and bone regulatory proteins. As conviction grew that aortic stenosis has a genesis similar to atherosclerosis, the hypothesis that statins might be able to alter the progression of the disease also grew. Various retrospective studies confirmed the benefits of statin use at an earlier stage of the disease, but some disappointing results were demonstrated by randomized clinical trials.
No takes yet. Share an insight, caveat, or question.
Mookadam et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: